Recurrent Primary Peritoneal Carcinoma Active Not Recruiting Phase 3 Trials for Ifosfamide (DB01181)

IndicationStatusPhase
DBCOND0031168 (Recurrent Primary Peritoneal Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00954174Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity CancerTreatment